Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,047,020 papers from all fields of science
Search
Sign In
Create Free Account
PD 173074
Known as:
PD-173074
, PD173074
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyrimidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract PD4-08: A microenvironment secretome screen reveals FGF2 as a mediator of resistance to anti-estrogens and PI3K/mTOR pathway inhibitors in ER+ breast cancer
K. Shee
,
Jw Hinds
,
+13 authors
T. Miller
2018
Corpus ID: 80196163
Despite the clinical success of anti-estrogen therapies, phosphatidylinositol 3-kinase inhibitors (PI3Ki), and mechanistic target…
Expand
2017
2017
Estudio de los mecanismes moleculares que promueven la progresión del carcinoma escamoso de piel
Pilar Simón Extremera
2017
Corpus ID: 134693611
El carcinoma escamoso (SCC) es el segundo tumor de piel mas frecuente en humanos caucasicos. Estudios recientes demuestran que el…
Expand
2017
2017
to elevation of its circulating levels in uremia Kidney fi broblast growth factor 23 does not contribute
M. Mace
,
E. Gravesen
,
+4 authors
E. Lewin
2017
Corpus ID: 207878275
Fibroblast growth factor 23 (FGF23) secreted by osteocytes is a circulating factor essential for phosphate homeostasis. High…
Expand
2015
2015
Massive degradation in FGFR/Akt/Erk signaling by arsenic trioxide and FGFR inhibitor PD173074 in squamous cell lung carcinoma SK-MES-1
S. Lam
,
L. Leung
,
J. Ho
2015
Corpus ID: 74064796
This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary…
Expand
2014
2014
[FGFR1 selective inhibitor PD173074 can reduce proliferation and induce apoptosis of nasopharyngeal carcinoma].
H. Luan
,
Yunfei Xu
,
Tingting Fu
,
Y. Luan
,
C. Yuan
Lin chuang er bi yan hou tou jing wai ke za zhi…
2014
Corpus ID: 21961123
OBJECTIVE To study the influence of PD173074 on proliferation and apoptosis of nasopharyngeal carcinoma. METHOD With…
Expand
2014
2014
Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
E. Bello
,
Rosaria Chilà
,
+7 authors
G. Damia
2014
Corpus ID: 58720214
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Lucitanib (S80881, formerly E-3810) is a novel tyrosine…
Expand
2013
2013
Abstract 5652: Activation of FGF2-FGFR1 pathway in EGFR-mutant lung cancer cell line with long-term gefitinib exposure.
H. Terai
,
K. Soejima
,
+13 authors
T. Betsuyaku
2013
Corpus ID: 71723965
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Many of the patients with non-small cell lung cancer…
Expand
2012
2012
Inhibition of activated FGFR2 in endometrial cancer cells induces cell death despite PTEN abrogation
S. Byron
,
M. Gartside
,
+5 authors
P. Pollock
2012
Corpus ID: 15710274
KRAS activation and PTEN inactivation are frequent events in endometrial tumorigenesis, occurring in 10-30% and 26-80% of…
Expand
2011
2011
Cancer: Hope for smoking-associated lung cancer?
Alexandra Flemming
Nature reviews. Drug discovery
2011
Corpus ID: 21177599
Squamous cell carcinoma, a subtype of non-small cell lung cancer (NSCLC), is strongly associated with smoking, and the prognosis…
Expand
2011
2011
Abstract 4845: Tumor cell line profiling of eighteen cancer therapeutics to evaluate relationships between tumor genotypes and cancer cell sensitivities
Y. Ovechkina
,
C. O'Day
,
+9 authors
B. Nelson
2011
Corpus ID: 76088016
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL In vitro cellular response profiling of tumor human…
Expand